195 related articles for article (PubMed ID: 37179119)
21. Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma.
Diao X; Guo C; Li S
Thorac Cancer; 2023 Jan; 14(3):320-330. PubMed ID: 36507553
[TBL] [Abstract][Full Text] [Related]
22. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
23. Identification and validation of an anoikis-related genes signature for prognostic implication in papillary thyroid cancer.
Zhao R; Lu Y; Wan Z; Qiao P; Yang L; Zhang Y; Huang S; Chen X
Aging (Albany NY); 2024 Apr; 16(8):7405-7425. PubMed ID: 38663918
[TBL] [Abstract][Full Text] [Related]
24. Predicting the immune microenvironment and prognosis with a anoikis - related signature in breast cancer.
Lu X; Yuan Q; Zhang C; Wang S; Wei W
Front Oncol; 2023; 13():1149193. PubMed ID: 37469408
[TBL] [Abstract][Full Text] [Related]
25. Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients.
Zhu Z; Geng R; Zhang Y; Liu J; Bai J
J Immunol Res; 2023; 2023():8727884. PubMed ID: 36726489
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Novel Hypoxia Score for Predicting Prognosis and Immune Microenvironment in Rectal Cancer.
Yang K; Shen Z; Yin N; Quan J; Wang M; Gao K
Front Surg; 2022; 9():881554. PubMed ID: 35548187
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and
Dong Y; Xu C; Su G; Li Y; Yan B; Liu Y; Yin T; Mou S; Mei H
Front Immunol; 2023; 14():1122570. PubMed ID: 37275895
[TBL] [Abstract][Full Text] [Related]
28. A Novel Immune-Related Gene Signature Predicts Prognosis of Lung Adenocarcinoma.
Ma C; Li F; Wang Z; Luo H
Biomed Res Int; 2022; 2022():4995874. PubMed ID: 35437508
[TBL] [Abstract][Full Text] [Related]
29. Construction and validation of a novel aging-related gene signature and prognostic nomogram for predicting the overall survival in ovarian cancer.
Liu L; Zhao J; Du X; Zhao Y; Zou C; Zhou H; Li W; Yan X
Cancer Med; 2021 Dec; 10(24):9097-9114. PubMed ID: 34825509
[TBL] [Abstract][Full Text] [Related]
30. A novel anoikis-related risk model predicts prognosis in patients with colorectal cancer and responses to different immunotherapy strategies.
Yang L; Xu F
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10879-10892. PubMed ID: 37318595
[TBL] [Abstract][Full Text] [Related]
31. Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma.
Zhang JS; Pan RS; Tian XB
Front Oncol; 2023; 13():1156663. PubMed ID: 37035149
[TBL] [Abstract][Full Text] [Related]
32. Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer.
Zhang W; Liu T; Jiang L; Chen J; Li Q; Wang J
Front Genet; 2022; 13():1001239. PubMed ID: 36425071
[No Abstract] [Full Text] [Related]
33. A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer.
Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Wang Y
J Ovarian Res; 2023 Apr; 16(1):86. PubMed ID: 37120633
[TBL] [Abstract][Full Text] [Related]
34. Construction of a lipid metabolism-related and immune-associated prognostic score for gastric cancer.
Dai J; Li Q; Quan J; Webb G; Liu J; Gao K
BMC Med Genomics; 2023 May; 16(1):93. PubMed ID: 37138287
[TBL] [Abstract][Full Text] [Related]
35. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
36. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
37. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
[TBL] [Abstract][Full Text] [Related]
38. Anoikis Patterns in Cervical Cancer: Identification of Subgroups and Construction of a Novel Risk Model for Predicting Prognosis and Immune Response.
Xiang X; Ding J
Front Biosci (Landmark Ed); 2023 Nov; 28(11):287. PubMed ID: 38062824
[TBL] [Abstract][Full Text] [Related]
39. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
40. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
